<DOC>
	<DOCNO>NCT01213589</DOCNO>
	<brief_summary>The purpose post-market release registry collect additional information concern safety , performance health economic data respect Medtronic VALIANT Thoracic Stent Graft Xcelerant Delivery System treatment descend thoracic aortic dissection .</brief_summary>
	<brief_title>The VIRTUE Post Marketing Surveillance Registry</brief_title>
	<detailed_description>The patient device use registry Medtronic VALIANT Thoracic Stent Graft System receive CE mark approval March 2005 . The Medtronic VALIANT Thoracic Stent Graft Xcelerant Delivery System design treat disease descend thoracic aorta include limited aneurysms dissection . The VALIANT Stent Graft design exclude aneurysm , false lumen site rupture restore blood flow stent graft lumen . The device intend use either patient candidate conventional surgical repair , patient candidate conventional surgical repair due pre-existing risk factor . This registry prospective , non-randomized , single-arm , multi-center , European clinical registry patient diagnose descend thoracic aortic dissection . For registry standard hospital procedure respect patient interventional care thoracic aortic disease follow . This descriptive registry specific hypotheses statistically test .</detailed_description>
	<criteria>Patient equal 18 year age ; old require local regulation . Patient indication treatment either endovascular stent graft implantation either acute , subacute chronic Type B dissection . Patient amenable stentgraft treatment ( accordance IFU ) . The patient willing able cooperate registry procedure require followup visit . The patient legal guardian sign patient inform consent form , include data privacy authorization ( criterion applicable patient present emergency rupture dissection legal representative available informed consent request surgical procedure ) . Patients thoracic dissection optimal treatment observation medical management . Patient current non aortic medical condition life expectancy le one year . The patient participate another device drug study ( patient must complete followup phase previous study least 30 day prior enrolment registry ) . Time interval medical indication surgical intervention endovascular procedure exceed 4 month ( 122 day ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>descend</keyword>
	<keyword>thoracic</keyword>
	<keyword>aortic</keyword>
	<keyword>dissection</keyword>
	<keyword>Valiant</keyword>
	<keyword>Medtronic</keyword>
	<keyword>Type B</keyword>
	<keyword>VIRTUE</keyword>
	<keyword>stent</keyword>
</DOC>